bioAffinity Technologies, Inc.

BIAF · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$4-$3-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0$0$1$1
Other Non-Cash$3$1$0$0
Operating Cash Flow-$2-$3-$2-$2
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0-$0-$0
Financing Activities
Debt Repay.$0-$0-$0-$0
Stock Issued$11$3$1$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$0$0$0
Financing Cash Flow$9$3$1$2
Forex Effect$0$0$0$0
Net Chg. in Cash$7$0-$1$0
Supplemental Information
Beg. Cash$1$0$1$1
End Cash$8$1$0$1
Free Cash Flow-$2-$3-$2-$2
bioAffinity Technologies, Inc. (BIAF) Financial Statements & Key Stats | AlphaPilot